HK Stock MarketDetailed Quotes

JW THERAP-B (02126)

Watchlist

2.920
-0.020-0.68%

Market Closed Jan 16 16:05 CST

1.22BMarket Cap-1.80P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

JW THERAP-B (02126) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

22.50%106.35M

-8.99%158.22M

-1.05%86.82M

19.32%173.86M

32.93%87.74M

373.10%145.7M

--66.01M

--30.8M

----

Operating income

22.50%106.35M

-8.99%158.22M

-1.05%86.82M

19.32%173.86M

32.93%87.74M

373.10%145.7M

66.01M

30.8M

Cost of sales

4.27%-41.23M

5.53%-80.9M

-0.33%-43.07M

1.51%-85.64M

-0.12%-42.93M

-299.71%-86.95M

---42.88M

---21.75M

----

Operating expenses

4.27%-41.23M

5.53%-80.9M

-0.33%-43.07M

1.51%-85.64M

-0.12%-42.93M

-299.71%-86.95M

-42.88M

-21.75M

Gross profit

48.86%65.12M

-12.36%77.32M

-2.38%43.75M

50.14%88.22M

93.74%44.81M

549.60%58.76M

23.13M

9.05M

Selling expenses

23.21%-58.49M

-24.04%-140.41M

-26.60%-76.17M

40.70%-113.2M

28.75%-60.17M

-11.80%-190.88M

-82.88%-84.45M

-1,186.80%-170.73M

---46.18M

---13.27M

Administrative expenses

45.66%-32.19M

14.27%-120.07M

24.73%-59.23M

22.09%-140.05M

13.45%-78.69M

10.80%-179.76M

13.49%-90.92M

12.87%-201.52M

-29.74%-105.1M

-217.31%-231.29M

Research and development expenses

39.05%-92.04M

31.58%-282.99M

30.26%-151.01M

-1.42%-413.62M

-10.54%-216.53M

1.59%-407.82M

-5.59%-195.89M

-84.00%-414.4M

-125.50%-185.51M

-65.47%-225.22M

Special items of operating profit

-3,116.39%-155.83M

33.32%-140.68M

93.89%-4.85M

-54.92%-210.97M

5.36%-79.34M

-835.36%-136.18M

-2,713.15%-83.83M

-36.01%18.52M

-35.35%3.21M

570.19%28.94M

Operating profit

-10.48%-273.44M

23.15%-606.84M

36.52%-247.51M

7.74%-789.61M

9.73%-389.92M

-12.75%-855.88M

-29.49%-431.96M

-72.19%-759.08M

-110.71%-333.58M

-115.38%-440.84M

Financing income

-6.59%12.42M

-16.44%28.43M

-11.86%13.3M

105.78%34.03M

179.41%15.09M

99.31%16.54M

179.21%5.4M

141.09%8.3M

1,434.92%1.93M

89.07%3.44M

Financing cost

-3.19%-6.25M

1.57%-12.22M

-8.42%-6.05M

-82.92%-12.42M

-106.85%-5.58M

-152.12%-6.79M

-402.61%-2.7M

-249.61%-2.69M

-85.17%-537K

43.01%-770K

Special items of earning before tax

----

104.17%51.15M

110.47%51.49M

-185.67%-1.23B

Earning before tax

-11.24%-267.27M

23.10%-590.62M

36.84%-240.27M

9.23%-768M

11.38%-380.42M

-20.48%-846.14M

-52.93%-429.25M

57.79%-702.33M

56.82%-280.7M

-162.74%-1.66B

After-tax profit from continuing operations

-11.24%-267.27M

23.10%-590.62M

36.84%-240.27M

9.23%-768M

11.38%-380.42M

-20.48%-846.14M

-52.93%-429.25M

57.79%-702.33M

56.82%-280.7M

-162.74%-1.66B

Earning after tax

-11.24%-267.27M

23.10%-590.62M

36.84%-240.27M

9.23%-768M

11.38%-380.42M

-20.48%-846.14M

-52.93%-429.25M

57.79%-702.33M

56.82%-280.7M

-162.74%-1.66B

Profit attributable to shareholders

-11.24%-267.27M

23.10%-590.62M

36.84%-240.27M

9.23%-768M

11.38%-380.42M

-20.48%-846.14M

-52.93%-429.25M

57.79%-702.33M

56.82%-280.7M

-162.74%-1.66B

Basic earnings per share

-10.34%-0.64

23.53%-1.43

37.63%-0.58

9.22%-1.87

11.43%-0.93

-17.05%-2.06

-47.89%-1.05

86.04%-1.76

92.87%-0.71

-29.47%-12.61

Diluted earnings per share

-10.34%-0.64

23.53%-1.43

37.63%-0.58

9.22%-1.87

11.43%-0.93

-17.05%-2.06

-47.89%-1.05

86.04%-1.76

92.87%-0.71

-29.47%-12.61

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Guan Huang Chen Fang Certified Public Accountants

PricewaterhouseCoopers

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	22.50%106.35M	-8.99%158.22M	-1.05%86.82M	19.32%173.86M	32.93%87.74M	373.10%145.7M	--66.01M	--30.8M	----	----
Operating income	22.50%106.35M	-8.99%158.22M	-1.05%86.82M	19.32%173.86M	32.93%87.74M	373.10%145.7M	66.01M	30.8M
Cost of sales	4.27%-41.23M	5.53%-80.9M	-0.33%-43.07M	1.51%-85.64M	-0.12%-42.93M	-299.71%-86.95M	---42.88M	---21.75M	----	----
Operating expenses	4.27%-41.23M	5.53%-80.9M	-0.33%-43.07M	1.51%-85.64M	-0.12%-42.93M	-299.71%-86.95M	-42.88M	-21.75M
Gross profit	48.86%65.12M	-12.36%77.32M	-2.38%43.75M	50.14%88.22M	93.74%44.81M	549.60%58.76M	23.13M	9.05M
Selling expenses	23.21%-58.49M	-24.04%-140.41M	-26.60%-76.17M	40.70%-113.2M	28.75%-60.17M	-11.80%-190.88M	-82.88%-84.45M	-1,186.80%-170.73M	---46.18M	---13.27M
Administrative expenses	45.66%-32.19M	14.27%-120.07M	24.73%-59.23M	22.09%-140.05M	13.45%-78.69M	10.80%-179.76M	13.49%-90.92M	12.87%-201.52M	-29.74%-105.1M	-217.31%-231.29M
Research and development expenses	39.05%-92.04M	31.58%-282.99M	30.26%-151.01M	-1.42%-413.62M	-10.54%-216.53M	1.59%-407.82M	-5.59%-195.89M	-84.00%-414.4M	-125.50%-185.51M	-65.47%-225.22M
Special items of operating profit	-3,116.39%-155.83M	33.32%-140.68M	93.89%-4.85M	-54.92%-210.97M	5.36%-79.34M	-835.36%-136.18M	-2,713.15%-83.83M	-36.01%18.52M	-35.35%3.21M	570.19%28.94M
Operating profit	-10.48%-273.44M	23.15%-606.84M	36.52%-247.51M	7.74%-789.61M	9.73%-389.92M	-12.75%-855.88M	-29.49%-431.96M	-72.19%-759.08M	-110.71%-333.58M	-115.38%-440.84M
Financing income	-6.59%12.42M	-16.44%28.43M	-11.86%13.3M	105.78%34.03M	179.41%15.09M	99.31%16.54M	179.21%5.4M	141.09%8.3M	1,434.92%1.93M	89.07%3.44M
Financing cost	-3.19%-6.25M	1.57%-12.22M	-8.42%-6.05M	-82.92%-12.42M	-106.85%-5.58M	-152.12%-6.79M	-402.61%-2.7M	-249.61%-2.69M	-85.17%-537K	43.01%-770K
Special items of earning before tax	----	----	----	----	----	----	----	104.17%51.15M	110.47%51.49M	-185.67%-1.23B
Earning before tax	-11.24%-267.27M	23.10%-590.62M	36.84%-240.27M	9.23%-768M	11.38%-380.42M	-20.48%-846.14M	-52.93%-429.25M	57.79%-702.33M	56.82%-280.7M	-162.74%-1.66B
After-tax profit from continuing operations	-11.24%-267.27M	23.10%-590.62M	36.84%-240.27M	9.23%-768M	11.38%-380.42M	-20.48%-846.14M	-52.93%-429.25M	57.79%-702.33M	56.82%-280.7M	-162.74%-1.66B
Earning after tax	-11.24%-267.27M	23.10%-590.62M	36.84%-240.27M	9.23%-768M	11.38%-380.42M	-20.48%-846.14M	-52.93%-429.25M	57.79%-702.33M	56.82%-280.7M	-162.74%-1.66B
Profit attributable to shareholders	-11.24%-267.27M	23.10%-590.62M	36.84%-240.27M	9.23%-768M	11.38%-380.42M	-20.48%-846.14M	-52.93%-429.25M	57.79%-702.33M	56.82%-280.7M	-162.74%-1.66B
Basic earnings per share	-10.34%-0.64	23.53%-1.43	37.63%-0.58	9.22%-1.87	11.43%-0.93	-17.05%-2.06	-47.89%-1.05	86.04%-1.76	92.87%-0.71	-29.47%-12.61
Diluted earnings per share	-10.34%-0.64	23.53%-1.43	37.63%-0.58	9.22%-1.87	11.43%-0.93	-17.05%-2.06	-47.89%-1.05	86.04%-1.76	92.87%-0.71	-29.47%-12.61
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?